Stay updated on Archway Study: PDS vs Monthly Ranibizumab in Wet AMD Clinical Trial
Sign up to get notified when there's something new on the Archway Study: PDS vs Monthly Ranibizumab in Wet AMD Clinical Trial page.

Latest updates to the Archway Study: PDS vs Monthly Ranibizumab in Wet AMD Clinical Trial page
- Check7 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.1%
- Check14 days agoChange DetectedThe web page has been updated to include new facility names and locations, as well as several new research articles related to the Port Delivery System with Ranibizumab. Notably, the previous location details have been removed, and several medical topics related to macular degeneration have also been deleted.SummaryDifference9%
- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check44 days agoChange DetectedThe page has been updated to reflect a new version, v2.16.10, and the previous service alert regarding planned maintenance has been removed.SummaryDifference0.9%
- Check58 days agoChange DetectedThe web page has been updated from version 2.16.5 to version 2.16.6.SummaryDifference0.1%
Stay in the know with updates to Archway Study: PDS vs Monthly Ranibizumab in Wet AMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Archway Study: PDS vs Monthly Ranibizumab in Wet AMD Clinical Trial page.